Ryan Barnes

Ryan Barnes

A Look at Caterpillar's Blowout Quarter

Ryan Barnes submits:The Secular Trends Portfolio gobbled up a few more scraps of alpha Tuesday as largest holding Caterpillar (CAT) breezed past consensus estimates for $.22 per share in Q2. Net profit (that’s right folks, net) came in at $.60/sh, or $371 million. Ex-out the one-time restructuring costs and Caterpillar posted $.72, so it appears that the first quarter of 2009 will be the only one with a net loss. Considering the company’s leverage to early-business cycle activity, that’s an astounding feat. CAT shares are the destination of choice should they toss up a great quarter: They [CAT] have footprints in many businesses on the leading edge of the business cycle, so their comments tomorrow will very quickly determine if CAT shares will hit new highs for the year (around $42) or stay mired in the mid-30’s as has been their fate thus far. Caterpillar is the second-largest holding in the Secular Trends Portfolio, and barring a meltdown within the CAT Financial division, nothing will change the overweighting of this stock.Complete Story »

Weekly Preview: Earnings Upside Continues

Ryan Barnes submits:The weak dollar trade is back on today, as the USD is down against most major currencies. This has pushed gold, copper, and other hard commodities up to or near their highest levels of the month. Days like this are generally good for the Secular Trends Portfolio, and in early morning trade the model has picked up a quick 2 percentage points on the strength of Las Vegas Sands ((LVS) - up 12%), Petrobras ((PBR) - up 4%), Alcoa ((AA) - up 3.5%), and Peabody ((BTU) - up 4%). Caterpillar a Key Earnings Report Tomorrow Caterpillar (CAT) is seeing strong early buying today ahead of Tuesday’s earnings report. CAT shares are up 6% this morning in advance of what is - for these eyes - the most anticipated earnings call of the season. The folks at the local “home office” paper in Peoria, IL did a nice preview piece Sunday that talks about the difficulties in estimating what kind of numbers Caterpillar will report. Sales are sure to remain down year-over-year in a big way (35-40%), but the recent weakness of the dollar is a strength to this company that does more than half its business overseas. And after taking big charges in the first quarter to curtail production and lay off workers, how much more was needed in Q2?Complete Story »

Healthcare: Branded Pharma Out, Diagnostics/Generics In

Ryan Barnes submits:When you lose, Don’t lose the lesson - The Dalai Lama For the better part of 5 months I’ve been kicking myself over not dumping Pfizer (PFE) from the Secular Trends Portfolio the day they announced the Wyeth merger. The second I heard about the deal I honestly thought the TV announcer had made a mistake; “No no, it couldn’t be Wyeth. That would just be stupid”Complete Story »

Syndicate content